Characterization of the Effects of Cyclooxygenase-2 Inhibition in the Regulation of Apoptosis in Human Small and Non–Small Cell Lung Cancer Cell Lines
- 30 June 2007
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 14 (9) , 2678-2684
Abstract
Background Cyclooxygenase-2 enzyme (COX-2) is overexpressed in human non–small cell lung cancer (NSCLC) but is not expressed in small cell lung cancer. Selective COX-2 inhibitors have been shown to...Keywords
This publication has 32 references indexed in Scilit:
- Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsBritish Journal of Cancer, 2006
- Celecoxib Shown Effective in Preventing Colon PolypsJNCI: Journal of the National Cancer Institute, 2006
- Cyclooxygenase‐2 as a signaling molecule in radiation‐induced bystander effectMolecular Carcinogenesis, 2006
- Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogeneticsNature Reviews Cancer, 2006
- The Targeting of Phosphoinositide-3 Kinase Attenuates Pulmonary Metastatic Tumor Growth Following LaparotomyAnnals of Surgery, 2006
- Phosphoinositide 3-Kinase Accelerates Postoperative Tumor Growth by Inhibiting Apoptosis and Enhancing Resistance to Chemotherapy-induced ApoptosisJournal of Biological Chemistry, 2005
- Surgically Induced Accelerated Local and Distant Tumor Growth is Significantly Attenuated by Selective COX-2 InhibitionThe Annals of Thoracic Surgery, 2005
- Selective Cyclooxygenase-2 Inhibitor Rofecoxib (Vioxx) Induces Expression of Cell Cycle Arrest Genes and Slows Tumor Growth in Human Pancreatic CancerJournal of Gastrointestinal Surgery, 2002
- Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 ExpressionJournal of Biological Chemistry, 2002
- Reduction of Intestinal Neoplasia With Adenomatous Polyposis Coli Gene Replacement and COX-2 Inhibition Is AdditiveJournal of Gastrointestinal Surgery, 2002